IGM Biosciences, Inc. IGMS
Set alert
1.27 0.00 0.00%
At close · Aug 14
1.27 Day range 1.27
6.15 52-week range 22.50
- YTD
- -79.21%
- 1 year
- -85.70%
- Open
- 1.27
- Prev close
- 1.27
- Mkt cap
- 387.11M
- Vol
- 1.59M
- Avg vol
- 268.09K
- EPS
- -3.61
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 1.27
- High
- 1.27
- Forward P/E
- -2.71
- Beta
- 0.19
- Short ratio
- 11.22
- Inst. own
- 63.97%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 14, 2024
- 50-d avg
- 12.15
- 200-d avg
- 10.57
- 1y target
- 19.73
Financial health
Altman Z-Score
-3.76 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
3 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
Valuation
P/E -1.9×
FY 2017 5y median -3.3× FY 2024
P/S 138×
FY 2017 5y median 138× FY 2024
P/B 7.7×
FY 2017 5y median -1.2× FY 2024
P/FCF -2.3×
FY 2017 5y median -7.1× FY 2024
EV/EBITDA -1.9×
FY 2017 5y median -2.8× FY 2024
EV/Sales 145×
FY 2017 5y median 145× FY 2024
FCF Yield -43.0%
FY 2017 5y median -14.0% FY 2024
Profitability
Gross Margin -240.1%
FY 2017 5y median -240.1% FY 2024
Operating Margin -7785.7%
FY 2017 5y median -7785.7% FY 2024
Net Margin -7308.5%
FY 2017 5y median -7308.5% FY 2024
ROE -406.4%
FY 2017 5y median 37.3% FY 2024
ROIC -88.7%
FY 2017 5y median -60.4% FY 2024
ROA -73.7%
FY 2017 5y median -53.9% FY 2024
Growth (YoY)
Revenue 25.8%
FY 2017 FY 2024
Operating Income 20.8%
FY 2017 FY 2024
EPS (diluted) 31.2%
FY 2017 FY 2024
Free Cash Flow 22.4%
FY 2017 FY 2024
Financial Health
Current Ratio 5.1×
FY 2017 5y median 8.7× FY 2024
Quick Ratio 5.1×
FY 2017 5y median 8.7× FY 2024
Debt / Equity 0.9×
FY 2017 5y median -0.1× FY 2024
Net Debt / EBITDA -0.1×
FY 2017 5y median 0.4× FY 2024
Interest Coverage 0.0×
FY 2017 5y median 0.0× FY 2024
Dividends
Dividend Yield 0.0%
FY 2017 5y median 0.0% FY 2024
Payout Ratio 0.0%
FY 2017 5y median 0.0% FY 2024
Annual · latest fiscal year ends 2024-12-31